Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 29 employees as of March 31, 2026. The number of employees increased by 6 or 26.09% since the number was last reported on December 31, 2025.
Employees
29
Change
6
Growth
26.09%
Revenue / Employee
n/a
Profits / Employee
-$3,993,310
Market Cap
207.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 29 | 6 | 26.09% |
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 145 |
| AC Immune | 122 |
| Keros Therapeutics | 87 |
| Compugen | 75 |
| Protara Therapeutics | 46 |
| AN2 Therapeutics | 21 |
| Galectin Therapeutics | 9 |
WHWK News
- 19 days ago - Whitehawk Therapeutics initiated with an Outperform at Leerink - TheFly
- 25 days ago - Whitehawk, Biocytogen collaborate for bispecific antibody ADC development - TheFly
- 25 days ago - Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development - Business Wire
- 5 weeks ago - Whitehawk Therapeutics initiated with a Buy at B. Riley - TheFly
- 7 weeks ago - Whitehawk Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Whitehawk Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Whitehawk Therapeutics presents real-world analysis on SEZ6 - TheFly
- 2 months ago - Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 - PRNewsWire